Skip to main content
Fig. 3 | Skeletal Muscle

Fig. 3

From: CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Fig. 3

Enhanced migratory response of T lymphocytes from DMD patients correlates with disease severity. a Migration of T lymphocytes through endothelial cells. b Fibronectin-driven migration. Relative numbers of CD49dhiCD4+ and CD49dhiCD8+ migrating cells in healthy controls and in the different groups of DMD patients, subdivided according to their ability to walk. The number of DMD patients analyzed in each group appears in parentheses. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page